Determination of the structural requirements for palmitoylation of p63

A. Schweizer, J. Rohrer, S. Kornfeld

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

Palmitoylation of p63, a type II membrane protein localized in the endoplasmic reticulum, is induced in a reversible manner by the drug brefeldin A. To study the requirements for palmitoylation, mutant forms of p63 were expressed in COS cells and analyzed by metabolic labeling with [3H]palmitate, immunoprecipitation, and SDS-polyacrylamide gel electrophoresis. By investigating deletion and point mutations, Cys100 in the 106-amino acid cytoplasmic tail of p63 has been identified as the site of acylation. Site-directed mutagenesis of residues 99-105 together with cytoplasmic tail truncation mutants showed that the amino acids surrounding Cys100 are not critical for palmitoylation of this residue. Analysis of a chimeric construct between p63 and the plasma membrane protein dipeptidylpeptidase IV further revealed that p63 palmitoylation is not dependent on its transmembrane domain. In contrast, the six amino acid distance between the end of the predicted transmembrane domain and the palmitoylation site was found to be essential for proper acylation of p63.

Original languageEnglish
Pages (from-to)9638-9644
Number of pages7
JournalJournal of Biological Chemistry
Volume270
Issue number16
DOIs
StatePublished - Jan 1 1995

Fingerprint Dive into the research topics of 'Determination of the structural requirements for palmitoylation of p63'. Together they form a unique fingerprint.

  • Cite this